These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 5359763)
41. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Lyons JS; Severns ML Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914 [TBL] [Abstract][Full Text] [Related]
43. [Retinal pigment epithelium--the point about safety of antimalarial agents]. Vanheesbeke A Bull Soc Belge Ophtalmol; 2007; (304):47-58. PubMed ID: 17718227 [TBL] [Abstract][Full Text] [Related]
44. Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis. Arden GB; Kolb H Br Med J; 1966 Jan; 1(5482):270-3. PubMed ID: 5902055 [No Abstract] [Full Text] [Related]
45. Monitoring patients on antimalarials: where are we now? Easterbrook M Can J Ophthalmol; 2012 Dec; 47(6):465-70. PubMed ID: 23217497 [No Abstract] [Full Text] [Related]
47. [Monthly question: ophthalmologic monitoring of synthetic antimalarial agents. Which method to use?]. Ann Dermatol Venereol; 1994; 121(5):440-2. PubMed ID: 7702275 [No Abstract] [Full Text] [Related]
48. Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate? Schwartzman S; Samson CM Rheum Dis Clin North Am; 2019 Aug; 45(3):359-367. PubMed ID: 31277749 [TBL] [Abstract][Full Text] [Related]
49. [The effect of antimalarials on the function of the retina. Electroretinographic studies]. Svĕrák J; Salavec M; Peregrin J Cesk Oftalmol; 1965 Sep; 21(5):370-8. PubMed ID: 5833943 [No Abstract] [Full Text] [Related]
50. Antimalarial agents in pregnancy. Motta M; Tincani A; Faden D; Zinzini E; Chirico G Lancet; 2002 Feb; 359(9305):524-5. PubMed ID: 11853823 [No Abstract] [Full Text] [Related]
51. [Hemeralopia as the leading symptom of hereditary eye diseases]. Hommer K Wien Klin Wochenschr; 1967 Jun; 79(24):476-9. PubMed ID: 5301294 [No Abstract] [Full Text] [Related]
52. [Monitoring and prevention of iatrogenic ocular effect in general therapy]. Le Rebeller MJ; Lanneluc C; Lotte C Annee Ther Clin Ophtalmol; 1981; 32():269-92. PubMed ID: 7348132 [No Abstract] [Full Text] [Related]
53. [Statistical results of 700 electrophysiologic tests (ERG) in patients without ophthalmologic manifestations treated with synthetic antimalarials for rheumatologic or dermatologic disease]. Rigaudière F; Pizzato M; Albuisson E; Le Gargasson JF; Grall Y Ophtalmologie; 1990; 4(3):254-9. PubMed ID: 2250958 [TBL] [Abstract][Full Text] [Related]
54. Electro-oculograms in the early diagnosis of chloroquine retinopathy. Weinreb MS Calif Med; 1967 Mar; 106(3):183-8. PubMed ID: 6039185 [TBL] [Abstract][Full Text] [Related]
55. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Kellner U; Renner AB; Tillack H Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425 [TBL] [Abstract][Full Text] [Related]
56. Discussion: modifications of the ERG during chloroquine intoxications. Mawas E Trans Ophthalmol Soc U K (1962); 1966; 86():115-7. PubMed ID: 5226562 [No Abstract] [Full Text] [Related]
57. [Ocular involvement in chloroquine therapy]. Godel V; Nemet P; Stein R Harefuah; 1972 Jul; 83(2):60-3. PubMed ID: 5068910 [No Abstract] [Full Text] [Related]